banner add

F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.

from NYT > Health https://ift.tt/L20DSZA
via IFTTT

No comments

Genetic Data From Over 20,000 U.S. Children Misused for ‘Race Science’

The National Institutes of Health failed to protect brain scans that an international group of fringe researchers used to argue for the inte...

Theme images by PLAINVIEW. Powered by Blogger.